NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹325 Cr | ₹309 Cr | ₹303 Cr | ₹273 Cr | ₹22 Cr |
What is the latest Net Current Assets ratio of NATH BIOGENES (INDIA) ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹325 Cr |
| Mar2024 | ₹309 Cr |
| Mar2023 | ₹303 Cr |
| Mar2022 | ₹273 Cr |
| Mar2013 | ₹22 Cr |
How is Net Current Assets of NATH BIOGENES (INDIA) Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹325 Cr | 5.01 | |
| Mar2024 | ₹309 Cr | 1.92 | |
| Mar2023 | ₹303 Cr | 10.94 | |
| Mar2022 | ₹273 Cr | 1,164.10 | |
| Mar2013 | ₹22 Cr | - | |
Compare Net Current Assets of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹289.9 Cr | 6.1% | 8.6% | -6.3% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,388.0 Cr | 3.7% | -3.1% | -22.9% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,758.9 Cr | 9% | 20.6% | -31.6% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,056.8 Cr | 7.8% | 15.4% | -12.3% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,033.4 Cr | -1.9% | 18.1% | -21.9% | Stock Analytics | |
| INDO US BIOTECH | ₹214.9 Cr | -1.1% | 4.7% | -30.6% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 6.1% |
8.6% |
-6.3% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses